PL381833A1 - Konserwatywne epitopy rdzenia lipopolisacharydowego jako potencjalne szczepionki wielogatunkowe - Google Patents

Konserwatywne epitopy rdzenia lipopolisacharydowego jako potencjalne szczepionki wielogatunkowe

Info

Publication number
PL381833A1
PL381833A1 PL381833A PL38183305A PL381833A1 PL 381833 A1 PL381833 A1 PL 381833A1 PL 381833 A PL381833 A PL 381833A PL 38183305 A PL38183305 A PL 38183305A PL 381833 A1 PL381833 A1 PL 381833A1
Authority
PL
Poland
Prior art keywords
inner core
vaccine candidates
conserved inner
core lipopolysaccharide
epitopes
Prior art date
Application number
PL381833A
Other languages
English (en)
Inventor
Andrew Cox
James C. Richards
Original Assignee
National Research Council Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council Canada filed Critical National Research Council Canada
Publication of PL381833A1 publication Critical patent/PL381833A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0001—Archaeal antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
PL381833A 2004-05-14 2005-05-16 Konserwatywne epitopy rdzenia lipopolisacharydowego jako potencjalne szczepionki wielogatunkowe PL381833A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002467329A CA2467329A1 (en) 2004-05-14 2004-05-14 Inner core lps epitopes and uses thereof
US57148904P 2004-05-17 2004-05-17

Publications (1)

Publication Number Publication Date
PL381833A1 true PL381833A1 (pl) 2007-07-23

Family

ID=35452161

Family Applications (1)

Application Number Title Priority Date Filing Date
PL381833A PL381833A1 (pl) 2004-05-14 2005-05-16 Konserwatywne epitopy rdzenia lipopolisacharydowego jako potencjalne szczepionki wielogatunkowe

Country Status (3)

Country Link
CN (1) CN101014698A (pl)
CA (1) CA2467329A1 (pl)
PL (1) PL381833A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229513A1 (en) * 2008-09-05 2011-09-22 Cox Andrew D LPS Based Vaccines
CN105497885B (zh) * 2014-09-25 2019-02-15 普莱柯生物工程股份有限公司 一种亚单位疫苗及其制备方法和应用
WO2018083490A2 (en) * 2016-11-04 2018-05-11 The Secretary Of State For Environment, Food And Rural Affairs Polysaccharide and methods
CN109239341B (zh) * 2018-07-04 2021-08-24 西南大学 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用
EP4628527A3 (en) * 2019-09-24 2025-11-26 Biomedical Research Group Inc. Lipopolysaccharide production method
CN111850003A (zh) * 2020-07-09 2020-10-30 华中农业大学 一种重组表达的多杀性巴氏杆菌硫胺素周质结合蛋白及应用
CN115772506A (zh) * 2022-12-09 2023-03-10 内蒙古自治区农牧业科学院 一种溶血性曼氏杆菌plpe蛋白单克隆抗体及其制备方法和应用

Also Published As

Publication number Publication date
CN101014698A (zh) 2007-08-08
CA2467329A1 (en) 2005-11-14

Similar Documents

Publication Publication Date Title
IL209859A0 (en) Epitope analogs
SI2301961T2 (sl) Sklerostinski epitopi
PL3042914T3 (pl) Nowe immunogenne epitopy do immunoterapii
ATE462445T1 (de) Prrs-impfstoffe
EP2089051A4 (en) INCREASED IMMUNOGENICITY OF TUMOR ASSOCIATED ANTIGENES BY ADDITION OF ALPHA GAL EPITOPES
GB0605521D0 (en) Adjuvant
PL381833A1 (pl) Konserwatywne epitopy rdzenia lipopolisacharydowego jako potencjalne szczepionki wielogatunkowe
GB0512751D0 (en) New adjuvant
GB2428042B (en) P gingivalis vaccine
GB2439658B (en) Web-winding core
GB0516944D0 (en) Vaccine
GB0517719D0 (en) Vaccines containing pili
GB0406749D0 (en) Novel adjuvant
GB0521155D0 (en) Protective vaccine candidates
GB0521339D0 (en) Protective vaccine candidates
GB0507672D0 (en) Adjuvant
IL197737A0 (en) Antigen specific multi epitope vaccines
AP2007004280A0 (en) Immunological adjuvant emulsion
GB0624529D0 (en) Search & rescue aid
AU2005906665A0 (en) Identification of Immunodominant Epitopes
GB0413475D0 (en) Preparation of protective antigen
GB0605163D0 (en) Adjuvant
GB0715229D0 (en) Overseen hydro walker
GB0513191D0 (en) Vaccine
GB0514021D0 (en) Vaccine

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)